The phorbol myristate acetate (PMA)-differentiated myelomonocytic cell line, THP-1, and human alveolar macrophages contain the cysteine proteinase cathepsin L. This enzyme is synthesized as a 43-kD proenzyme and processed to the active 25-kD form. Differentiation of THP-1 cells in the presence of human serum resulted in a increase in the size of the vacuolar compartment and the accumulation of more 25-kD cathepsin L antigen, as compared with THP-1 cells differentiated in the presence of fetal calf serum. Cells cultured in both types of sera have equivalent levels of cathepsin L mRNA. Metabolic labeling experiments demonstrated equivalent rates of synthesis, processing to the active form, and persistence in both culture conditions. An extracellular source of enzyme was documented by immunoblotting human serum which demonstrated 25-kD cathepsin L antigen; furthermore, we demonstrated that both THP-1 cells, differentiated in human serum, and human alveolar macrophages take up the 43-kD proenzyme and process it to the 25-kD form. Thus, human serum contains a factor(s) that induces both a marked increase in the size of the vacuolar compartment in differentiated THP-1 cells and a novel pathway that is responsible for the uptake and processing of extracellular cathepsin L. The activity of this inducible pathway is a major determinant of levels of intracellular cathepsin L. Cathepsin L is a potent elastase and the regulation of its uptake and processing may play a role in the pathogenesis of disease processes characterized by the destruction of elastin, such as pulmonary emphysema. (J. Clin. Invest. 1990. 86:176-183.) 
Introduction
Current concepts regarding the pathogenesis of emphysema postulate that elastin degradation is a critical component in the development ofthis debilitating chronic lung disease (1) . It has been suggested that lung macrophages play an important role in the connective tissue destruction characteristic of this disorder (2) . We have previously reported that human macrophages are capable ofdegrading elastin by a contact-dependent process that involves one or more cysteine proteinases (3).
There is some controversy concerning the enzyme(s) involved in extracellular elastin degradation, however, in that Senior and colleagues (4) reported that human alveolar macrophages, after 24 h in culture, degrade elastin by a process that is inhibitable by tissue inhibitor of metalloproteinases (TIMP). In connective tissue matrices, the cooperative participation of the serine proteinases plasminogen activator and plasmin(ogen) is required for measurable elastolysis to take place (3, 5, 6) . Human alveolar macrophages synthesize and express cathepsin L, which is an acidic cysteine proteinase that is a potent elastase (7, 8) . This enzyme is synthesized as a 43-kD precursor and then processed to an active 25-kD enzyme via a 34-kD intermediate. The 34-kD intermediate also has some enzymatic activity (9). In addition to the intracellular accumulation of cathepsin L, it has also been reported that human alveolar macrophages secrete the 43-kD form ofthe enzyme in culture (7) .
We sought to examine the factors that regulate the accumulation of cathepsin L by human macrophages. In earlier work, it was demonstrated that human peripheral blood monocytes do not contain appreciable cathepsin L mRNA, whereas human alveolar macrophages contain demonstrable levels of a 1.5-kB mRNA transcript encoding for cathepsin L (7) . Thus, the expression of cathepsin L occurs at some point during the differentiation from monocyte to tissue macrophage. We used a human cell line (THP-1) as a model system to explore cathepsin L regulation. The THP-l cell line has myelomonocytic characteristics and can be differentiated into a macrophage-like cell by exposure to retinoids and phorbol esters (10, 11) . The data demonstrate that human macrophages have several independent mechanisms for cathepsin L accumulation and document the contribution of uptake of extracellular enzyme to steady-state intracellular cathepsin L levels.
Methods
Cell culture. THP-l cells were obtained from the American Type Culture Collection, Rockville, MD. Cells were cultured in RPMI-1640 with 100 ,g/ml streptomycin, 100 U/ml penicillin, 5 X 10-5 M 2-mercaptoethanol (RPMI), and 10% heat-inactivated (HI)' fetal calf serum (HIFCS; Hyclone Laboratories, Logan, UT). Cells were maintained at 370C, 100% humidity, and 5% CO2. Cells Human alveolar macrophages were collected as previously described (3) . In brief, normal volunteers underwent bronchoalveolar lavage under a protocol approved by the institutional committee for the protection of human subjects from research risks. The collected lavage specimen was placed on ice and then centrifuged at 300 g to pellet the cells. The cells were resuspended in Dulbecco's modified Eagle's medium (DME) with 20 mM Hepes, 100 U/ml penicillin, and 100 sg/ml streptomycin. These alveolar macrophages were then used for the experiments described below.
Measurement ofrates ofpinocytosis and quantitation ofthe size of the vacuolar compartment. Swanson and colleagues (12) have reported that the use of Lucifer yellow CH allows the determination of rates of pinocytosis and the size of the vacuolar compartment. The uptake of Lucifer yellow within the first hour represents pinocytotic ingestion; levels after 24 h are more reflective of the size of the larger endocytic compartment, which displays slower kinetics.
Differentiated THP-1 cells were incubated with 1 mg/ml Lucifer yellow (Molecular Probes, Eugene, OR) for 0-24 h at 370C, 100% humidity, 5% CO2. After 0-24 h, the cells were washed extensively with phosphate-buffered saline (PBS) and lysed in PBS/1% Triton X-100/0.5% deoxycholate. Fluorescence of intracellular Lucifer Yellow was measured in a fluorescence spectrophotometer (model 10S, Perkin-Elmer Corp., Norwalk, CT) with excitation at 428 nm and emission monitored at 540 nm. Preliminary experiments demonstrated that the uptake of Lucifer yellow was proportional to probe concentration. Rates of pinocytosis were measured by quantitating Lucifer yellow uptake over 30- Metabolic labeling and immunoprecipitation. Metabolic labeling, immunoprecipitation and autoradiography were done as previously reported, with minor modifications (7). 10 million differentiated THP-1 cells in 25-cm2 tissue culture flasks were labeled in 4 ml of methionine-free DME containing 1 mg/ml bovine serum albumin (BSA) and 500 ,Ci of [35Slmethionine for 2-6 h as noted at 37°C, 5% CO2, 100% humidity. 24-h labeling experiments were modified by including 10% (vol/vol) of methionine containing DME in the flask. After the labeling period, the cells were washed three times with PBS and then either lysed or changed to tissue culture media for the specified chase period. Cells were lysed in PBS plus 1% Triton X-100, 10 mM EDTA, 2 mM phenylmethanesulfonyl fluoride, 100 U/ml Trasyslol (Sigma Chemical Co.), and 0.5% deoxycholate. The cells were subjected to three cycles of freeze-thawing, scraped with a rubber policeman, and then clarified by centrifugation at 14,000 g for 15 min. Triton/0. 1% SDS and complexes were removed by boiling in reduced sample buffer and electrophoresed on SDS/10% (wt/vol) polyacrylamide gels. The gels were stained in Coomassie blue, destained, soaked in 16% salycylic acid/l% glycerol, and dried. Autoradiography was then performed using XR5 film at -70'C.
Western blotting. This was performed as previously described (7). Briefly, I07 THP-l cells or 8 X 106 human alveolar macrophages per sample were lysed as described above. After initial clarification by centrifugation, total cellular protein was extracted as described by Wessel and Flugge (18) . These pellets were resuspended in reduced sample buffer and electrophoresed on 10% SDS-PAGE. The electrophoresed proteins were then transferred to nitrocellulose by means ofa Transblot apparatus (Bio-Rad Laboratories, Richmond, CA) using buffers as described by Burnette (19) . Nonfat dried milk (5%, wt/vol) in PBS was used subsequently to block nonspecific protein adherence during the antibody staining. Primary antibody staining with rabbit anti-human cathepsin L was carried out for 2 h at room temperature. Secondary antibody staining was performed under similar conditions using '25I-coupled goat anti-rabbit IgG. After drying ofthe nitrocellulose filter, autoradiography was performed.
Uptake ofpro-cathepsin L. W138 VA13 fibroblasts were obtained from the American Type Culture Collection. These were cultured in DME/l0% HIFCS. Conditioned media containing pro-cathepsin L was made by washing confluent monolayers of fibroblasts three times with PBS. The cells were then incubated for 24 h in DME plus 10 mM NH4Cl. The NH4CI disrupts lysosomal pH gradients and results in the secretion of the proenzyme forms of lysosomal enzymes (20). The media was harvested at 24 h, centrifuged at 300 g to remove cellular debris, and then concentrated 100-200-fold using a positive-pressure filter (Amicon Corp., Danvers, MA). This concentrated media was then used as a source of pro-cathepsin L for Western blots.
Uptake demonstrated by Western blots was performed as follows: THP-I cells were differentiated with 18 nM PMA as described above. At 72 h postdifferentiation, the cells were changed to fresh media with or without the addition of concentrated W138 supernatant. 24 h later, I0' cells were lysed in PBS/l% Triton X-100 and Western blotting was performed as outlined above. These experiments were also performed in the presence of 10 mM mannose-6phosphate, 100 mM mannose, and 12.5 mg/ml fucoidan (all sugars obtained from Sigma Chemical Co.) in an attempt to delineate the pathways involved in uptake. Experiments involving human alveolar macrophages were performed by culturing freshly isolated macrophages in DME plus 0.25 mg/ml BSA. To this, supernatant with or without saccharides was added. After 24 h at 37°C, 5% CO2 cells were processed as outlined for THP-l cells.
Results
Differentiation induces cathepsin L synthesis. In the undifferentiated state, the THP-1 cell has myelomonocytic characteristics. It is similar to peripheral blood monocytes in that it does not contain detectable quantities of cathepsin L. Differentiation of THP-1 cells with 18 nM PMA results in a cell with the morphologic characteristics ofa macrophage, including adherence. Given the fact that differentiated peripheral blood monocytes and human alveolar macrophages synthesize cathepsin L, we sought to determine whether such differentiation results in the induction of cathepsin L synthesis (7). (12, (22) (23) (24) . Fig. 2 B shows in graphical form the results of four experiments (demonstrating that the vacuolar compartment is 85±38% larger) in cells cultured in human serum, using incubation with Lucifer yellow for 24 h and then measuring fluorescence of cell lysates. The 85% increase in vacuolar compartment size shown in Fig. 2 Comparison of cathepsin L mRNA levels. We performed Northern and dot blotting for cathepsin L mRNA to establish whether or not the difference in the observed protein levels was the result of an increase in steady-state cathepsin L mRNA levels. Fig. 4 displays the results of this analysis. Fig. 4 A displays a Northern blot comparing cathepsin L levels in cells cultured in either FCS or HS. The same blot was then reprobed for actin mRNA as a control for total RNA loaded in the lane. Fig. 4 A demonstrates that cathepsin L mRNA levels are comparable under the two culture conditions. This was confirmed by doing dot blots for cathepsin L mRNA on serial dilutions of RNA isolated from differentiated THP-l cells under the two different culture conditions (Fig. 4 B) . These analyses also demonstrated comparable cathepsin L mRNA levels. These mRNA level data (representative of six experiments) suggest that the factor(s) responsible for the increase in cathepsin L antigen do not change steady-state cathepsin L mRNA levels.
Cathepsin L translation and posttranslational processing.
We sought to establish whether the differences in antigen levels could be explained by differences in the rates of cathepsin L translation or in the rates of posttranslational processing. shows an experiment representative of the five performed, with a 24-h label followed by up to a 48-h chase. As we have previously described in human alveolar macrophages, cathepsin L is synthesized as a 43-kD proenzyme and is then processed to a 34-kD intermediate (7 One possible interpretation of these data is that the increase in the 25-kD antigen demonstrable in differentiated THP-1 cells in human serum is not the result of uptake and processing of 43-kD pro-cathepsin L, but rather that some factor in the W138 supernatant results in increased uptake of A * 5 B Figure 6 . Uptake of procathepsin L by THP-l cells. the 25-kD antigen that is abundant in human serum. To explore this possibility, we repeated the experiments using human alveolar macrophages cultured in serum-free conditions. Incubation with concentrated W138 supernatant was performed for 24 h in DME/0.25 mg/ml BSA. The data, a representative example ofwhich is illustrated in Fig. 7 , demonstrate that human alveolar macrophages display behavior identical to that of the THP-l cells cultured in human serum with respect to uptake of cathepsin L, in that they take up exogenous cathepsin L and process it to the 34-and 25-kD forms via a pathway that is not blocked by mannose, mannose-6-phosphate, or fucoidan. Densitometry of the immunoblots demonstrated uptake comparable to that seen in THP-I cells in human serum as demonstrated in Fig. 6 B (data not shown). These data suggest that the increase in intracellular antigen levels is the result of uptake and processing of the procathepsin L in the W138 supernatants, rather than an increase in uptake of the cathepsin L antigen in human serum.
The possibility that the accumulation of cathepsin L from the extracellular space was the result of an increase in fluid phase pinocytosis, rather than a more selective pathway, was evaluated by comparing the rates ofpinocytosis among THP-I cells cultured in the two different sera (12) . Measurements of the rate ofuptake ofLucifer yellow from 30 min to 4 h demonstrated no differences among the two culture conditions, suggesting that the increase in uptake of cathepsin L is not merely the result of an increase in the rate of nonspecific pinocytosis.
An attempt was made to remove cathepsin L antigen from human serum in order to dissociate the factor(s) responsible for the induction of the uptake pathway from cathepsin L antigen and therefore presumably demonstrate the absence of 25-kD cathepsin L on immunoblots ofTHP-I cells cultured in cathepsin L-depleted human serum. Unfortunately, the available quantities of anti-cathepsin L antibody were insufficient to allow construction of an anti-cathepsin L affinity column. As outlined earlier, attempts to fractionate serum on the basis of apparent molecular mass to deplete cathepsin L also failed, as the antigen is widely distributed throughout the gel filtration eluant, presumably as the result of protein binding in serum. We were therefore unable to generate cathepsin L-depleted human serum. Discussion This paper presents data addressing the regulation of intracellular levels of a lysosomal cysteine proteinase, cathepsin L. This acidic protease has broad substrate specificity, including the ability to degrade elastin. The data presented establish the fact that the expression of detectable levels of cathepsin L is the result of both the differentiation of myelomonocytic cells into macrophages (Fig. 1) and of the specific culture conditions to which the macrophages are exposed (Fig. 3) .
Differentiation of THP-l cells in the presence of human serum results in an 85% increase in the size of the vacuolar compartment, detectable by visual inspection and quantitated by the uptake of Lucifer yellow (Fig. 2) . This increase is accompanied by an increase in the amount of detectable intracellular cathepsin L. The data presented in this report establish that the increase in intracellular cathepsin L results from the acquisition and accumulation of the enzyme from an extracellular source. The data also demonstrate the PMA-induced differentiation alone does not result in the expression of cathepsin L uptake (Fig. 6 A) , but that the presence of human serum is required for demonstrable uptake activity. That this is the result of a factor(s) in human serum, as opposed to being prevented by an inhibitor in FCS, was confirmed by performing mixing experiments in which the cells were exposed to both FCS and human serum. These experiments demonstrated the same morphologic and antigenic changes as were seen in cells exposed to human serum alone. It has previously been reported in HeLa cells that incubation in human serum results in an increase in the number of visible vacuoles and an increase in the amount of acid phosphatase detectable cytochemically within the cells (30) . Ahearn and colleagues (31) reported a 129% increase in the number of vacuoles staining for acid phosphatase in HeLa cells exposed to 100% human serum, a finding similar to the 85% increase noted in this report.
We then sought to establish at what regulatory site the factor(s) are operating to produce the observed increase in cathepsin L levels in cells cultured in human serum. Analysis of the levels of cathepsin L mRNA demonstrated equivalent message levels in the two culture conditions. Further experiments showed no differences in the rates of synthesis of the 43-kD precursor and subsequent processing to the 25-kD active form in the two culture conditions. These data lead to the conclusion that the cells accumulate demonstrable cathepsin L antigen from an extracellular source.
Uptake of extracellular lysosomal enzymes is a well described process in fibroblasts and macrophages. Two principal pathways have been described, both of which depend on the recognition of saccharide residues on the glycosylated enzyme. The first is the mannose-6-phosphate receptor system (32). This consists of two receptors, one cation dependent and the other cation independent. One important function of this system is to target newly synthesized lysosomal enzyme precursors in the Golgi apparatus to the endosomal compartment. It has also been demonstrated to have the capability oftaking up extracellular enzyme as well. The second is the mannose/fucose receptor. Originally described in hepatic tissue, this receptor system has also been demonstrated to be present in alveolar macrophages (33) . As the name implies, this system recognizes mannose and fucose residues on glycoproteins and is capable of binding extracellular protein at the cell surface. Campbell demonstrated that alveolar macrophages were capable of ingesting a neutral serine proteinase, human neutrophil elastase, by a receptor-mediated process that also bound lactoferrin and cathepsin G and later releasing quantities of active enzyme in response to hypoxic stress (29, 34, 35) . This binding and uptake was blocked by fucoidan.
The data presented in this article demonstrate uptake of a lysosomal enzyme by a pathway independent of any of these described pathways. This was established by demonstrating uptake still takes place (Figs. 6 B and 7) in the presence of sufficient concentration of sugars to block binding of glycoproteins to the receptors (25) (26) (27) (28) (29) . The existence of such a pathway is supported by several lines of circumstantial evidence. The first stems from observations made in patients with I cell disease. I cell disease is an autosomal recessive disorder characterized by a defect of phosphorylation of lysosomal enzyme precursors. As a result, these precursors are not recognized by the mannose-6-phosphate receptor. In cultured fibroblasts from these patients, intracellular lysosomal enzyme levels are low and the precursors can be demonstrated to be secreted into the extracellular environment (36) . In other tissues, however, lysosomal enzyme levels are relatively normal, suggesting the existence of additional pathway(s) transporting precursors to the endosomal or lysosomal compartment (37) . In cells that are deficient in the expression of the mannose-6-phosphate receptor but are able to phosphorylate proenzymes appropriately, intracellular lysosomal enzyme levels are normal, once again suggesting an alternative pathway for lysosomal enzyme targeting (38) . The uptake of cathepsin L reported here occurs by a mechanism independent of the described pathways that depend on carbohydrate recognition, constituting yet another mechanism by which macrophages can potentially accumulate lysosomal enzyme(s). Whether or not this pathway accounts for observations in I cell disease or mannose-6-phosphate receptor deficient cells remains to be determined.
The possibility exists that this pathway involves the uptake of enzyme bound to a carrier protein. The fact that immunoblotting of serum subjected to gel filtration chromatography demonstrates that cathepsin L antigen appears in fractions ranging from > 75 to -25 kD suggests that a much of the cathepsin L antigen is bound to one or more proteins. The data presented using human alveolar macrophages cultured in serum-free conditions make uptake via a carrier protein seem less likely, or at least imply that if a carrier protein is involved, it is one synthesized and secreted by the macrophages themselves or is found in the concentrated supernatants from WI38 fibroblasts.
Previous reports concerning cathepsin L suggest that it should also be taken up by the mannose-6-phosphate pathway as well (39) . Our use of immunoblotting to demonstrate uptake may have precluded demonstration of mannose-6-phosphate-dependent uptake. As discussed earlier, the lack of sensitivity ofthe immunoblotting is demonstrated by the fact that cathepsin L is not seen in immunoblots of THP-l cells cultured in FCS, whereas more sensitive metabolic labeling studies demonstrate the presence of 25-kD cathepsin L in these cells. The fact that uptake of extracellular enzyme is demonstrable by immunoblotting suggests that much more cathepsin L is taken up by the pathway described here than by the mannose or mannose-6-phosphate pathways. This is consistent with the conclusion that the activity of this pathway is responsible for the accumulation of the majority of intracellular cathepsin L.
This role of extracellular enzyme uptake in determining intracellular levels of enzyme appears to be a novel mechanism for the regulation of lysosomal enzyme levels. In their report examining the induction of lysosomal enzymes in murine peritoneal macrophages, Morland and Morland (40) found that it is possible to selectively induce various lysosomal enzymes but that this induction was blocked by cycloheximide and concluded that the increase in enzyme levels is the result of increased synthesis. Odessey (41) , in examining lysosomal enzyme activity after burn injury to skeletal muscle, found that the increase in cathepsin D, B, H, and L activities was paralleled by increased glycoprotein synthesis and concluded that the observed increase was due to new enzyme synthesis. Livi and colleagues (42) examined the regulation of lysosomal a-mannosidase-1 in Dictyostelium discoideum and demonstrated that intracellular levels of enzyme were closely paralleled by the rate of precursor synthesis, which in turn was a function of a-mannosidase-l mRNA levels in the cell (42). The mechanism described in this report is distinctly different in that markedly different levels of intracellular cathepsin L are demonstrated under conditions where cathepsin L mRNA levels are identitical and the rate of precursor synthesis and subsequent processing to the 25-kD antigen are comparable.
The biologic role of this pathway remains to be defined. It is possible that the exogenous pathway has a function other than enzyme accumulation. The other reported pathways involved in the trafficking of lysosomal enzymes have been reported to have additional functions as well (43-49). The important role that this mechanism has in the determination of intracellular enzyme levels suggests that the regulation of this pathway may play an important role in the regulation of lysosomal proteolysis by human macrophages.
